HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats.

Abstract
Groups of 50 6-week-old male F344 rats were given a powdered diet containing 0, 0.125, 0.25, 0.5, 1, or 2% butylated hydroxyanisole [(BHA) CAS: 25013-16-5] for 104 weeks. The highest dose--2% BHA--induced significant increase in the incidence of squamous cell carcinoma of the forestomach. Papillomas of the forestomach developed in 20 and 100% of the rats given diets containing 1 and 2% BHA, respectively. The incidence of epithelial hyperplasia of the forestomach increased with the increased BHA doses, to 100% incidence at the highest dose. Thus the incidences of proliferative and neoplastic lesions of the forestomach were dose dependent.
AuthorsN Ito, S Fukushima, S Tamano, M Hirose, A Hagiwara
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 77 Issue 6 Pg. 1261-5 (Dec 1986) ISSN: 0027-8874 [Print] United States
PMID3467116 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Butylated Hydroxyanisole
Topics
  • Animals
  • Body Weight (drug effects)
  • Butylated Hydroxyanisole (toxicity)
  • Carcinoma, Squamous Cell (chemically induced)
  • Dose-Response Relationship, Drug
  • Hyperplasia
  • Papilloma (chemically induced)
  • Rats
  • Rats, Inbred F344
  • Stomach (pathology)
  • Stomach Neoplasms (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: